Fig. 4: Outcomes in adults with MASLD.
From: ECM formation and degradation during fibrosis, repair, and regeneration
According to Sanyal AJ et al.160, patients with chronic steatohepatitis are at higher risk of cardiovascular and renal adverse events than liver-related events. This schematic illustrates the organ death race driven by MASLD progression. (Line thickness represent probability of event per 100 patients).
